These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9047952)

  • 21. [Mitochondrial beta-oxidation defects].
    Woldseth B; Rootwelt T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):756-9. PubMed ID: 16541168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement.
    Lombardi A; de Lange P; Silvestri E; Busiello RA; Lanni A; Goglia F; Moreno M
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E497-502. PubMed ID: 19116374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism.
    Sharma V; Mustafa S; Patel N; Wambolt R; Allard MF; McNeill JH
    Eur J Pharmacol; 2009 Sep; 617(1-3):113-7. PubMed ID: 19573526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targets for modulation of fatty acid oxidation in the heart.
    Lopaschuk GD
    Curr Opin Investig Drugs; 2004 Mar; 5(3):290-4. PubMed ID: 15083595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of impairment of mitochondrial fatty acid beta-oxidation.
    Hasegawa T; Hori N; Du W
    Keio J Med; 2002 Jun; 51(2):100-6. PubMed ID: 12125906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diltiazem inhibits fatty acid oxidation in the isolated perfused rat liver.
    Nishiyama P; Ishii-Iwamoto EL; Bracht A
    Cell Biochem Funct; 1997 Dec; 15(4):223-8. PubMed ID: 9415967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired mitochondrial fatty acid oxidative flux in fibroblasts from a patient with malonyl-CoA decarboxylase deficiency.
    Bennett MJ; Harthcock PA; Boriack RL; Cohen JC
    Mol Genet Metab; 2001 Jul; 73(3):276-9. PubMed ID: 11461195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty acid oxidation by mitochondria from cold-fasted rats.
    MASORO EJ; PORTER E
    Tech Rep Arct Aeromed Lab US; 1961 Apr; 60(23):1-11. PubMed ID: 24545865
    [No Abstract]   [Full Text] [Related]  

  • 29. Introduction: the regulation of fatty acid oxidation in cells.
    Sherratt HS
    Biochem Soc Trans; 1994 May; 22(2):421-2. PubMed ID: 7958337
    [No Abstract]   [Full Text] [Related]  

  • 30. FAM13A, A Fatty Acid Oxidation Switch in Mitochondria. Friend or Foe in Chronic Obstructive Pulmonary Disease Pathogenesis?
    Hawkins GA; Mora AL
    Am J Respir Cell Mol Biol; 2017 Jun; 56(6):689-691. PubMed ID: 28569593
    [No Abstract]   [Full Text] [Related]  

  • 31. [Alkaptonuria. A brief outline of present-day knowledge of the biochemical aspects of the metabolic defect and pathogenesis of the disease (author's transl)].
    Koska L; Srsen S
    Cas Lek Cesk; 1982 Jun; 121(22):673-6. PubMed ID: 7105116
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of cortisone in alkaptonuria.
    BLACK RL
    J Am Med Assoc; 1954 Jul; 155(11):968-70. PubMed ID: 13162835
    [No Abstract]   [Full Text] [Related]  

  • 33. [Alcaptogenesis: unsolved biochemical problem].
    GONNARD P
    Rev Fr Etud Clin Biol; 1960 Mar; 5():251-3. PubMed ID: 13850965
    [No Abstract]   [Full Text] [Related]  

  • 34. Formation and disappearance of an endogenous uncoupling factor during swelling and contraction of mitochondria.
    WOJTCZAK L; LEHNINGER AL
    Biochim Biophys Acta; 1961 Aug; 51():442-56. PubMed ID: 14007889
    [No Abstract]   [Full Text] [Related]  

  • 35. Nature of the defect in alcaptonuria.
    ZANNONI VG; SEEGMILLER JE; LA DU BN
    Nature; 1962 Mar; 193():952-3. PubMed ID: 14009822
    [No Abstract]   [Full Text] [Related]  

  • 36. The nature of the defect in tyrosine metabolism in alcaptonuria.
    LA DU BN; ZANNONI VG; LASTER L; SEEGMILLER JE
    J Biol Chem; 1958 Jan; 230(1):251-60. PubMed ID: 13502394
    [No Abstract]   [Full Text] [Related]  

  • 37. [Disorders of organic acid metabolism].
    Tsuda M
    Ryoikibetsu Shokogun Shirizu; 1996; (15):81-4. PubMed ID: 9047952
    [No Abstract]   [Full Text] [Related]  

  • 38. [Myopathies with miscellaneous disorders related to mitochondrial fatty acid oxidation: defective synthesis of ketone body, long-chain fatty acid transport defect, and muscular coenzyme Q10 deficiency].
    Takusa Y; Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):90-4. PubMed ID: 11596461
    [No Abstract]   [Full Text] [Related]  

  • 39. Assays of fatty acid beta-oxidation activity.
    Bennett MJ
    Methods Cell Biol; 2007; 80():179-97. PubMed ID: 17445695
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluxing the mitochondria to insulin resistance.
    Watt MJ; Hevener AL
    Cell Metab; 2008 Jan; 7(1):5-6. PubMed ID: 18177719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.